Gingival crevicular fluid prostaglandin E2 and thiobarbituric acid reactive substance levels in smokers and non-smokers with chronic periodontitis following phase I periodontal therapy and adjunctive use of flurbiprofen

Journal of Periodontology

Volumn 78, Issue 1, 2007, Pages 104-111

  Kurtiş, Bülent ^a   Tüter, Gülay ^a   Serdar, Muhittin ^b   Pinar, Selin ^a   Demirel, Ilkim ^a   Toyman, Utku ^a  

^a GAZI UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chronic periodontitis; Flurbiprofen therapeutic use; Gingival crevicular fluid; Prostaglandin E2; Smoking; Thiobarbituric acid reactive substances

Indexed keywords

FLURBIPROFEN; PLACEBO; PROSTAGLANDIN E2; PROSTAGLANDIN E2 GINGIVAL CREVICULAR FLUID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROMETRY; HUMAN; MALE; PATHOGENESIS; PERIODONTITIS; PREVENTIVE DENTISTRY; RATING SCALE; SCORING SYSTEM; TOOTH PLAQUE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBONIC ANHYDRASE INHIBITORS; CHRONIC DISEASE; DENTAL SCALING; DINOPROSTONE; FEMALE; FLURBIPROFEN; GINGIVAL CREVICULAR FLUID; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTITIS; SMOKING; STATISTICS, NONPARAMETRIC; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33846685950     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.060217     Document Type: Article

References (47)

1. Rasmussen L, Hanström L, Lerner UH. Characterization of bone resorbing activity in gingival crevicular fluid from patients with periodontitis. J Clin Periodontol 2000;27:41-52.
2. 2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy. J Periodontol 1996;67:755-762.
3. 2 levels as a predictor of periodontal attachment loss. J Periodontal Res 1986; 21:101-112.
4. 2 concentrations in gingival crevicular fluid: Observations in untreated chronic periodontitis. J Clin Periodontol 2002; 29:15-20.
5. Chapple ILC. Reactive oxygen species and antioxidant in inflammatory diseases. J Clin Periodontol 1997;24: 287-296.
6. Tüter G, Kurtiş B, Serdar M. Interleukin-1β and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis. J Periodontol 2001;72:883-888.
7. Panjamurthy K, Manoharan S, Ramachandran CR. Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett 2005;10:255-264.
8. Rumley AG, Paterson JR. Analytical aspects of anti-oxidants and free radical activity in clinical biochemistry. Ann Clin Biochem 1998;35:181-200.
9. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.
10. Offenbacher S, Braswell LD, Loos AS, et al. Effects of flurbiprofen on the progression of periodontitis in Macaca mulatto. J Periodontal Res 1987;22:473-481.
11. Howell TH, Williams RC. Nonsteroidal anti-inflammatory drugs as inhibitors of periodontal disease progression. Crit Rev Oral Biol Med 1993;42:177-196.
12. Williams RC. Non-steroidal anti-inflammatory drugs for altering periodontal bone loss. J Dent Res 1999; 78:638-642.
13. Howell TH. Blocking periodontal disease progression with anti-inflammatory agents. J Periodontol 1993;64: 828-833.
14. Heasman PA, Seymour RA, Kelly PJ. The effect of systemically administered flurbiprofen as an adjunct to toothbrushing on the resolution of experimental gingivitis. J Clin Periodontol 1994;21:166-170.
15. Heasman PA, Offenbacher S, Collins JG, Edwards G, Seymour RA. Flurbiprofen in the prevention and treatment of experimental gingivitis. J Clin Periodontol 1993;20:732-738.
16. Apatzidou DA, Riggio MP, Kinane DF. Impact of smoking on the clinical, microbiological and immunological parameters of adult patients with periodontitis. J Clin Periodontol 2005;32:973-983.
17. Kinane DF, Chestnutt IG. Smoking and periodontal disease. Crit Rev Oral Biol Med 2000; 11:356-365.
18. Preber H, Bergström J, Linder LE. Occurrence of periopathogens in smoker and non-smoker patients. J Clin Periodontol 1992;19:667-671.
19. Stoltenberg JL, Osborn JB, Pihlström BL, et al. Association between cigarette smoking, bacterial pathogens, and periodontal status. J Periodontol 1993;64: 1225-1230.
20. Zambon JJ, Grossi SG, Machtei EE, Ho AW, Dunford R, Genco RJ. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol 1996;67:1050-1054.
21. Ryder MI, Fujitaki R, Johnson G, Hyun W. Alterations of neutrophil oxidative burst by in vitro smoke exposure: Implications for oral and systemic diseases. Ann Periodontol 1998;3:76-87.
22. Selby C, Drost E, Brown D, Howie S, MacNee W. Inhibition of neutrophil adherence and movement by acute cigarette smoke exposure. Exp Lung Res 1992; 18:813-827.
23. Boström L, Linder LE, Bergström J. Clinical expression of TNF-α in smoking associated periodontal disease. J Clin Periodontol 1998b;25:767-773.
24. Boström L, Linder LE, Bergström J. Smoking and crevicular fluid levels of IL-6 and TNF-α in periodontal disease. J Clin Periodontol 1999;26:352-357.
25. Boström L, Linder LE, Bergström J. Smoking and GCF levels of IL-1β and IL-1ra in periodontal disease. J Clin Periodontol 2000;27:250-255.
26. Rawlinson A, Grummitt JM, Walsh TF, Douglas CWI. Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. J Clin Periodontol 2003;30:42-48.
27. Grossi SG, Zambon J, Machtei EE, et al. Effects of smoking and smoking cessation on healing after mechanical periodontal therapy. J Am Dent Assoc 1997; 128:599-607.
28. Kinane DF, Radvar M. The effect of smoking on mechanical and antimicrobial periodontal therapy. J Periodontol 1997;68:467-472.
29. Tomasi C, Wennström JL. Locally delivered doxycycline improves the healing following non-surgical periodontal therapy in smokers. J Clin Periodontol 2004; 31:589-595.
30. Palmer RM, Matthews JP, Wilson RF. Non-surgical periodontal treatment with and without adjunctive metronidazole in smokers and non-smokers. J Clin Periodontol 1999;26:158-163.
31. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and oral condition. Acta Odontol Scand 1964;22:121-135.
32. Löe H. The gingival index, plaque index, and the retention index systems. J Periodontol 1967;38:610-616.
33. Griffiths GS, Curtis MA, Wilton JM. Selection of a paper with optimum properties for the collection of gingival crevicular fluid. J Periodontal Res 1988;23:33-38.
34. Bergström J. Oral hygiene compliance and gingivitis expression in cigarette smokers. Scand J Dent Res 1990;98:497-503.
35. Tonetti MS. Cigarette smoking and periodontal diseases: Etiology and management of disease. Ann Periodontol 1998;3:88-101.
36. van der Weijden GA, De Slegte C, Timmerman MF, van der Velden U. Periodontitis in smokers and non-smokers: Intra-oral distribution of pockets. A retrospective study. J Clin Periodontol 2001;28:955-960.
37. Hotz G. Drug therapy of post-operative and post-traumatic edema (in German). ZWR 1986;95:256-261.
38. Buduneli N, Vardar S, Atilla G, Sorsa T, Luoto H, Baylas H. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. J Periodontol 2002;73:103-109.
39. 2α and clinical parameters of chronic periodontitis. J Periodontol 2003; 74:57-63.
40. 2, and matrix metalloproteinase-8 in refractory periodontitis sites in smokers and non-smokers. Acta Odontol Scand 1999; 57:77-82.
41. 2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 2002;29:384-391.
42. Alavi AL, Palmer RM, Odell EW, Coward PY, Wilson RF. Elastase in gingival crevicular fluid from smokers and non-smokers with chronic inflammatory periodontal disease. Oral Dis 1995;1:110-114.
43. Heasman L, Stacey F, Preshaw PM, McCracken GI, Hepburn S, Heasman PA. The effect of smoking on periodontal treatment response: A review of clinical evidence. J Clin Periodontol 2006;33:241-253.
44. Pucher JJ, Shibley O, Dentino AR, Ciancio SG. Results of limited initial periodontal therapy in smokers and non-smokers. J Periodontol 1997;68:851-856.
45. Zuabi O, Machtei EE, Ben-Aryeh H, Ardekian L, Peled M, Laufer D. The effect of smoking and periodontal treatment on salivary composition in patients with established periodontitis. J Periodontol 1999;70:1240-1246.
46. Preshaw PM, Hefti AF, Bradshaw MH. Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. J Clin Periodontol 2005;32:610-616.
47. Williams RC, Paquette DW, Offenbacher S, et al. Treatment of periodontitis by local administration of minocycline microspheres: A controlled trial. J Periodontol 2001;72:1535-1544.